Document version control

Revision History

Version Date

v31.0 24/12/21

Section/ Appendix Summary of Changes

Section A

Section 8.2 Updated table ‘vaccine shelf life of vaccines’

Section 8.5.1

Section 8.5.2 Amendments to permissible stock movement, indicating that all cold chain requirements are required to be met Added paragraph in section ‘Restriction on Transport Durations’ for Paediatric Pfizer

Section 9.1.6 New section ‘Paediatric Pfizer (5 to 11 years) Vaccines Quantities and Unit.

Table 9.2

Heading amendment to clarify these consumables are for the Pfizer vaccine. The table has been updated to remove items no longer supplied as part of this pack Table 9.3 Saline added as now an ‘order as required’ item

Table 9.4 AstraZeneca consumables table added to include the flu+ syringe Section 9.2.1 Updated ‘Delivery temperature and expiry dates’ section

Section B

Section 16.1 Introduction paragraph updated. Table 18.3 Pfizer booster interval updated to 4 months.

Section 18.3 ‘Active monitoring: Post Vaccine Symptom Check’ section updated. This will be sent out to up to 25% of consumers. Updated information about the group of people being contacted.

Section C

New section: Paediatric Pfizer COVID-19 Vaccines (for age 5 to 11 years)

Section D

Updated to include AstraZeneca booster. Note: A prescription is still required.

Section E

Section 35 NIBS chapter updated with 5- to 11-year-old information. Under ‘Pre-event’.

Section 36.4

Section 36.6 Adverse events after observation period updated with more information on Pfizer and AstraZeneca adverse events.

Added sentence in the last paragraph ‘Please provide as much detail as possible about the error that occurred, any actions that were taken at the time of the event, and pending actions.’

Appendices No changes

v32.0 03/02/22

Section A

Section 8.2 Updated information around syringe labels

Section 8.6.2 Updated information around transportation of the Paediatric Pfizer

Section 10.2 Addition: Providers must contact their immunisation coordinator before disposing of any vaccines as per the National Standards

for Vaccine Storage and Transportation for Immunisation

Providers 2017.

Section B

Section 17 Updated information around syringe labels Section 18 Table 18.3 Booster interval updated from 4 months to 3 months (93 days). Section 18 Table 18.5 Updated ‘Record information’ section to clarify the information that needs to be recorded can be found (incl. diluent information).

Section C

Site readiness

Updated Site readiness Table to include bag valve mask resuscitator and airways suitable for children Section 22 Updated information around syringe labels Section 22.1 Updated ‘Number of doses per vial for age 5-11 years’

Section 23 Table 23.5 Updated ‘Record information’ section to include diluent information

Section D

Section 26 Updated information around syringe labels

Section E

Section 35

Section 36.5 Updated ‘Affected persons under the Vaccinations Order’ section to include the update around COVID-19 booster vaccinations Update ‘Pre-event: Booking an appointment’ section with the booster interval of 3 months (93 days).

Appendices

Appendix I

• Clarifying what incidents should follow this notification process • Updated Sac table (V4.0) with new examples Appendix K Updated IPC guidance with the COVID-19 protection framework